Skip to content

A comparative study efficacy of Hyaluronic acid and Triamcinolone acetonide in injection therapies for lateral epicondylitis : A randomized controlled trial

A comparative study efficacy of Hyaluronic acid and Triamcinolone acetonide in injection therapies for lateral epicondylitis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250525001
Enrollment
68
Registered
2025-05-25
Start date
2024-08-26
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral epicondylitis lateral epicondylitis, Hyaluronic acid, Triamcinolone acetonide

Interventions

Periarticular injection Sodium Hyaluronate (500-730KDa) 20mg/2ml,Periarticular injection Triamcinolone acetonide10mg/ml with NSS 1ml
Experimental Drug,Active Comparator Drug
Hyaluronic acid,Triamcinolone acetonide

Sponsors

Thammasat university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18-60 years old. 2. History at least 3 months of pain at the lateral epicondyle. 3. Positive provocation test more than 2/3 (Cozens, Mills, and Maudley tests) 4. VAS score on hand grip strength at least 50mm at initial diagnosis.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or breastfeeding 2. History of elbow surgery 3. History of previous injection treatment 4. Nerve entrapment or cervical radiculopathy 5. Inflammatory or rheumatological disease 6. Allergy to Hyaluronic acid or Triamcinolone acetonide

Design outcomes

Primary

MeasureTime frame
Pain score at rest and hand grip strength test after injection at 1, 3 and 6 month after intervention Symptom severity score

Secondary

MeasureTime frame
DASH-TH score at 1, 3 and 6 month after intervention Disability/Symptom score,Grip strength at 1, 3 and 6 month after intervention kilogram,Post injection pain at time of injection Symptom severity score after injection ,Adverse event at 1, 3 and 6 month after intervention Skin rash/flare, Skin hypopigmentation, Subcutaneous atrophy , Skin infection

Countries

Thailand

Contacts

Public ContactPeetipat Thanomsub

Thammasat university hospital

peetipat24@gmail.com0841527278

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026